These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15964936)

  • 1. Enzyme inhibitor screening using a homogeneous proximity-based immunoassay for estradiol.
    Kokko L; Johansson N; Lövgren T; Soukka T
    J Biomol Screen; 2005 Jun; 10(4):348-54. PubMed ID: 15964936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homogeneous noncompetitive immunoassay for 17beta-estradiol based on fluorescence resonance energy transfer.
    Kokko T; Kokko L; Lövgren T; Soukka T
    Anal Chem; 2007 Aug; 79(15):5935-40. PubMed ID: 17602670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved homogeneous proximity-based screening assay of potential inhibitors of 17beta-hydroxysteroid dehydrogenases.
    Kokko L; Jaakohuhta S; Lindroos P; Soukka T
    Assay Drug Dev Technol; 2006 Dec; 4(6):671-8. PubMed ID: 17199505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual-step fluorescence resonance energy transfer-based quenching assay for screening of caspase-3 inhibitors.
    Valanne A; Malmi P; Appelblom H; Niemelä P; Soukka T
    Anal Biochem; 2008 Apr; 375(1):71-81. PubMed ID: 18211811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upconversion fluorescence resonance energy transfer in a homogeneous immunoassay for estradiol.
    Kuningas K; Ukonaho T; Päkkilä H; Rantanen T; Rosenberg J; Lövgren T; Soukka T
    Anal Chem; 2006 Jul; 78(13):4690-6. PubMed ID: 16808483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particulate and soluble Eu(III)-chelates as donor labels in homogeneous fluorescence resonance energy transfer based immunoassay.
    Kokko L; Kokko T; Lövgren T; Soukka T
    Anal Chim Acta; 2008 Jan; 606(1):72-9. PubMed ID: 18068773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors.
    Laplante Y; Rancourt C; Poirier D
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):146-53. PubMed ID: 18812208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of homogeneous single-label fluorometric binding assays: fluorescence polarization and dual-parametric quenching resonance energy transfer technique.
    Härmä H; Sarrail G; Kirjavainen J; Martikkala E; Hemmilä I; Hänninen P
    Anal Chem; 2010 Feb; 82(3):892-7. PubMed ID: 20047278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of high-throughput spermidine synthase activity assay using homogeneous time-resolved fluorescence.
    Enomoto K; Nagasaki T; Yamauchi A; Onoda J; Sakai K; Yoshida T; Maekawa K; Kinoshita Y; Nishino I; Kikuoka S; Fukunaga T; Kawamoto K; Numata Y; Takemoto H; Nagata K
    Anal Biochem; 2006 Apr; 351(2):229-40. PubMed ID: 16472757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
    Laplante Y; Cadot C; Fournier MA; Poirier D
    Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
    Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
    Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective insensitivity of ZR-75-1 human breast cancer cells to 2-methoxyestradiol: evidence for type II 17beta-hydroxysteroid dehydrogenase as the underlying cause.
    Liu ZJ; Lee WJ; Zhu BT
    Cancer Res; 2005 Jul; 65(13):5802-11. PubMed ID: 15994956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a biological screening system for the evaluation of highly active and selective 17beta-HSD1-inhibitors as potential therapeutic agents.
    Kruchten P; Werth R; Marchais-Oberwinkler S; Frotscher M; Hartmann RW
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):154-7. PubMed ID: 18984028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homogeneous dual-parameter assay for prostate-specific antigen based on fluorescence resonance energy transfer.
    Kokko T; Liljenbäck T; Peltola MT; Kokko L; Soukka T
    Anal Chem; 2008 Dec; 80(24):9763-8. PubMed ID: 19012418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A homogeneous time-resolved fluorescence detection of telomerase activity.
    Gabourdes M; Bourgine V; Mathis G; Bazin H; Alpha-Bazin B
    Anal Biochem; 2004 Oct; 333(1):105-13. PubMed ID: 15351286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of bisubstrate inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: overview and perspectives.
    Fournier D; Poirier D; Mazumdar M; Lin SX
    Eur J Med Chem; 2008 Nov; 43(11):2298-306. PubMed ID: 18372081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone.
    Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D
    Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focused libraries of 16-substituted estrone derivatives and modified e-ring steroids: inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
    Vicker N; Lawrence HR; Allan GM; Bubert C; Smith A; Tutill HJ; Purohit A; Day JM; Mahon MF; Reed MJ; Potter BV
    ChemMedChem; 2006 Apr; 1(4):464-81. PubMed ID: 16892382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homogeneous assay based on anti-Stokes' shift time-resolved fluorescence resonance energy-transfer measurement.
    Laitala V; Hemmilä I
    Anal Chem; 2005 Mar; 77(5):1483-7. PubMed ID: 15732934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design, synthesis and in vitro characterization of potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estrone.
    Möller G; Deluca D; Gege C; Rosinus A; Kowalik D; Peters O; Droescher P; Elger W; Adamski J; Hillisch A
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6740-4. PubMed ID: 19836949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.